Who
Juan A. Sabater
Director
Company insider
Files Form 4 as: Director and 10% owner, Harmony Biosciences Holdings.
In numbers
- Trades disclosed
- 9
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 18 Aug 2020
- Last trade
- 14 May 2026
- Last filed
- 18 May 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 14 May 2026filed 18 May 2026 | HRMY Harmony Biosciences Holdingsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —21,872 at $0.00 | filing |
| 14 May 2026filed 18 May 2026 | HRMY Harmony Biosciences Holdingsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —21,872 at $0.00 | filing |
| 28 Aug 2025filed 2 Sep 2025 | HRMY Harmony Biosciences HoldingsPharmaceuticals | SEC FORM 4 Code J | —6,618,033 | filing |
| 15 May 2025filed 16 May 2025 | HRMY Harmony Biosciences Holdingsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —14,522 at $0.00 | filing |
| 29 May 2024filed 31 May 2024 | HRMY Harmony Biosciences Holdingsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —6,336 at $0.00 | filing |
| 25 May 2023filed 26 May 2023 | HRMY Harmony Biosciences Holdingsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —5,224 at $0.00 | filing |
| 20 May 2022filed 24 May 2022 | HRMY Harmony Biosciences Holdingsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —4,742 at $0.00 | filing |
| 20 May 2021filed 14 Jun 2021 | HRMY Harmony Biosciences Holdingsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —7,246 at $0.00 | filing |
| 18 Aug 2020filed 20 Aug 2020 | HRMY Harmony Biosciences Holdingsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —9,012 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.